
Sign up to save your podcasts
Or


While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:
By American Society for Clinical Pathology4.6
4848 ratings
While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:

91,297 Listeners

78,688 Listeners

43,837 Listeners

38,950 Listeners

30,109 Listeners

172,037 Listeners

10,972 Listeners

113,121 Listeners

56,944 Listeners

17,003 Listeners

369,956 Listeners

99,698 Listeners

59,604 Listeners

2,303 Listeners

11,013 Listeners